Dr. Dwaipayan Saha

About

I am a physician-scientist and second-year PhD candidate in Interdisciplinary Health Sciences at UTEP,
working in the Metabolic, Nutrition and Exercise Research (MiNER) Laboratory under Dr. Sudip Bajpeyi. My research is on investigation the neurocardiac regulation in progression of cardiovascular dieases.

Employment

• The University of Texas at El Paso Doctoral fellow
  2024 - Present
• Indian Institute of Chemical Biology Project Assistant
  2023 - 2024
• University of Calcutta Research Trainee
  2023 - 2023

Education

• West Bengal University of Health Sciences Doctor
  2015 - 2022

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• Immune effector cell-associated neurotoxicity syndrome: integrative mechanisms, predictive biomarkers, and translational pathways for prevention in CAR T-cell therapy
  Frontiers in Neurology 2026 DOI: 10.3389/fneur.2026.1739021
  +Save
• Burden of MASLD and liver fibrosis: evidence from Phenome India cohort
  The Lancet Regional Health - Southeast Asia 2026 DOI: 10.1016/j.lansea.2026.100723
  +Save
• Dysregulated Skeletal Muscle Lipid Handling Drives Myocardial Mitochondrial Dysfunction Through ASK-1 and PPARγ Signaling
  Lipidology 2026 DOI: 10.3390/lipidology3010005
  +Save
• Assessing Inter-platform Variability of Blood Parameters across Three Automated Platforms: Report from Multi-centric Phenome India Study
  2026 DOI: 10.64898/2026.01.24.26344729
  +Save
• Deciphering the burden of chromosomal disorders in India, bridging the gap between clinical reality and documented evidence: a systematic review and meta-epidemiological mapping of congenital and acquired abnormalities
  The Nucleus 2025 DOI: 10.1007/s13237-025-00617-3
  +Save
• Immune Checkpoint Restoration as a Therapeutic Strategy to Halt Diabetes-Driven Atherosclerosis
  Biology 2025 DOI: 10.3390/biology14121731
  +Save
• Unveiling the Burden of MASLD and Liver Fibrosis in India: Novel Insights from the Phenome India Study into fibrosis without MASLD
  2025 DOI: 10.1101/2025.10.11.25337761
  +Save
• The Neuro-Immune Axis in Cardiomyopathy: Molecular Mechanisms, Clinical Phenotypes, and Therapeutic Frontiers
  Immuno 2025 DOI: 10.3390/immuno5040045
  +Save
• Dual targeting of miR-33 and miR-92a in atherosclerosis: mechanistic insights, therapeutic potential, and translational challenges
  ExRNA 2025 DOI: 10.55092/exrna20250011
  +Save
• Exploring the potential link between human papillomavirus infection and coronary artery disease: a review of shared pathways and mechanisms
  Molecular and Cellular Biochemistry 2025 DOI: 10.1007/s11010-025-05236-9
  +Save